1. Sun, Shijie, Wang, Kai, Guo, Deyu, Shen, Hongchang, Du, Jiajun. 2024. Identification of the key DNA damage response genes for predicting immunotherapy and chemotherapy efficacy in lung adenocarcinoma based on bulk, single-cell RNA sequencing, and spatial transcriptomics. In Computers in biology and medicine, 171, 108078. doi:10.1016/j.compbiomed.2024.108078. https://pubmed.ncbi.nlm.nih.gov/38340438/
2. Cai, Fenglin, Yang, Xiuding, Ma, Gang, Dong, Cheng, Deng, Jingyu. 2024. EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-κB signalling activation independent of hydroxylase activity. In British journal of cancer, 130, 597-612. doi:10.1038/s41416-023-02546-x. https://pubmed.ncbi.nlm.nih.gov/38184692/
3. Pescador, Nuria, Cuevas, Yolanda, Naranjo, Salvador, Landázuri, Manuel O, Del Peso, Luis. . Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. In The Biochemical journal, 390, 189-97. doi:. https://pubmed.ncbi.nlm.nih.gov/15823097/
4. Zhang, Gang, Wang, Jianqiang, Tan, Wei, Sun, Yi, Li, Hang. 2021. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis. In Acta histochemica, 123, 151752. doi:10.1016/j.acthis.2021.151752. https://pubmed.ncbi.nlm.nih.gov/34274607/
5. Lin, Ling, Cai, Jianhua. 2020. Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation. In Journal of cellular biochemistry, 121, 4377-4385. doi:10.1002/jcb.29620. https://pubmed.ncbi.nlm.nih.gov/31904147/
6. Fu, Jian, Menzies, Keon, Freeman, Robert S, Taubman, Mark B. 2007. EGLN3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability. In The Journal of biological chemistry, 282, 12410-8. doi:. https://pubmed.ncbi.nlm.nih.gov/17344222/
7. Shi, Yuan-Xiang, Dai, Peng-Hui, Chen, Tao, Yan, Jian-Hua. 2024. Comprehensive analysis and experimental verification reveal the molecular characteristics of EGLN3 in pan-cancer and its relationship with the proliferation and apoptosis of lung cancer. In Heliyon, 10, e33206. doi:10.1016/j.heliyon.2024.e33206. https://pubmed.ncbi.nlm.nih.gov/39021988/
智鼠故事 
